Matterhorn Capital Management’s Pfizer PFE Stock Holding History

Matterhorn Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.34M	Sell	41,777 -5,463	-12%	-$183K	0.89%	24
2016 Q2	$1.58M	Sell	47,240 -29,423	-38%	-$939K	1%	22
2016 Q1	$2.16M	Sell	76,663 -44,103	-37%	-$1.26M	1.4%	34
2015 Q4	$3.7M	Buy	120,766 +15,486	+15%	+$487K	1.69%	32
2015 Q3	$3.14M	Buy	+105,280	New	+$3.38M	1.51%	33

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Matterhorn Capital Management's PFE Position: Q3 2016 in Review

Matterhorn Capital Management reduced its Pfizer (PFE) stake by 12% in Q3 2016, selling an estimated $183K and leaving 41,777 shares worth $1.34M. The position accounts for 0.89% of the portfolio, ranked #24.

Matterhorn Capital Management first reported a position in PFE in Q3 2015 and has held it in 5 quarters since. The position peaked at $3.7M in Q4 2015. 1,964 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

Matterhorn Capital Management held 41,777 shares of Pfizer worth $1.34M as of Q3 2016.
Matterhorn Capital Management sold 5,463 Pfizer shares in Q3 2016, an estimated $183K.
Pfizer made up 0.89% of Matterhorn Capital Management's portfolio in Q3 2016, its #24 holding.
Matterhorn Capital Management first reported a position in Pfizer in Q3 2015 and has held it in 5 quarters since.
Matterhorn Capital Management's Pfizer position peaked at $3.7M in Q4 2015.
1,964 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on Matterhorn Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.